DAX-0,47 % EUR/USD+0,38 % Gold+0,50 % Öl (Brent)0,00 %

Knock-Outs

Merck to Present Data on MAVENCLAD(TM) (Cladribine Tablets) and Rebif® (interferon beta-1a) in Patients with Relapsing MS at EAN Congress 2017

- New data builds on company's longstanding commitment to MS Merck, a leading science and technology company, will present data from its neurology and immunology portfolio at the 3rd Congress of the European Academy of Neurology (EAN), …

Wertpapier: Merck

Meistgehandelte Knock-Outs auf wikifolio.com

Top & Flop

WKNArtBasiswertPerf. %
DD0DQJ
Endlos
+11.900,00
HU8GUM
Endlos
+7.900,00
DGX606
Endlos
+2.900,00
SC3YCM
Endlos
+1.900,00
CY6FGJ
Classic
+423,81
CY6G1V
Endlos
-93,75
CY6G1V
Endlos
-93,75
UW9UBN
Endlos
Alphabet (C)
-98,78
UW7UDZ
Endlos
-98,89
UW9LZ4
Endlos
-99,57

Über Knock-Outs